Understanding tumor localization in multiparametric MRI of the prostate—effectiveness of 3D printed models

Understanding tumor localization in multiparametric MRI of the prostate—effectiveness of 3D printed models

IntroductionUnderstanding tumor localization in multiparametric MRI (mpMRI) of the prostate is challenging for urologists but of great importance in mpMRI-fused prostate biopsy or radical prostatectomy. The aim was to evaluate the effectiveness of 3D printed models of the prostate to help urologists...

Full description

Bibliographic Details
Main Authors:	Maximilian Haack, Katja Reisen, Ahmed Ghazy, Kristina Stroh, Lisa Frey, Peter Sparwasser, Gregor Duwe, Rene Mager, Axel Haferkamp, Hendrik Borgmann
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Surgery
Subjects:	prostate prostate carcinoma prostate biopsy MRI of the prostate PI-RADS 3D printed prostate model
Online Access:	https://www.frontiersin.org/articles/10.3389/fsurg.2023.1264164/full

Similar Items

Biparametric Prostate MRI Shows Similar Diagnostic Accuracy Rates for Prostate Cancer Detection with Multiparametric MRI
by: Faruk Yencilek, et al.
Published: (2022-09-01)

Assessment of a novel smartglass-based point-of-care fusion approach for mixed reality-assisted targeted prostate biopsy: A pilot proof-of-concept study
by: P. Sparwasser, et al.
Published: (2022-07-01)

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
by: Xueqing Cheng, et al.
Published: (2021-02-01)

Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
by: Mehmet Coşkun, et al.
Published: (2021-02-01)

Performance of multiparametric prostate magnetic resonance imaging validated by targeted and systematic transperineal biopsies
by: Richard A. Hsi, et al.
Published: (2023-01-01)

Detection of individual prostate cancer via multiparametric magnetic resonance imaging in own material – initial experience
by: Paweł Porzycki, et al.
Published: (2019-12-01)

Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions
by: Caleb Natale, et al.
Published: (2021-12-01)

The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World Setting
by: Yannic Volz, et al.
Published: (2023-08-01)

Utility of Multiparametric Magnetic Resonance Imaging as a Predictor of Clinically Significant Prostate Cancer in a Sub-Saharan African Population
by: Mariah Kerubo Obino, et al.
Published: (2022-04-01)

Utilization of Multiparametric MRI of Prostate in Patients under Consideration for or Already in Active Surveillance: Correlation with Imaging Guided Target Biopsy
by: Jinxing Yu, et al.
Published: (2020-06-01)

Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
by: Rui Su, et al.
Published: (2022-07-01)

Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge
by: Caterina Gaudiano, et al.
Published: (2023-06-01)

PI-RADS v2.1 evaluation of prostate “nodule in nodule” variants: clinical, imaging, and pathological features
by: MingHua Sun, et al.
Published: (2024-03-01)

The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3
by: Hai Zhu, et al.
Published: (2022-06-01)

Fusion Biopsy, not Cognitive, Is the New Gold Standard
by: Alessandro Marquis, et al.
Published: (2023-03-01)

Fusion Biopsy, not Cognitive, Is the New Gold Standard
by: Alessandro Marquis, et al.
Published: (2023-03-01)

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
by: Paulius Aliukonis, et al.
Published: (2017-04-01)

Multiparametric MRI and MR Spectroscopic Imaging of Prostate Lesions with Implementation of PI-RADS and Histopathological Correlation: A Prospective Analysis
by: Reddy Ravikanth, et al.
Published: (2019-01-01)

The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
by: Chung Un Lee, et al.
Published: (2021-10-01)

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
by: Muhsin Balaban, et al.
Published: (2019-01-01)

Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy
by: Shuanbao Yu, et al.
Published: (2020-11-01)

Morbidity following transperineal prostate biopsy: Our experience in 8.500 men
by: Pietro Pepe, et al.
Published: (2022-06-01)

Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer
by: Juan Morote, et al.
Published: (2022-04-01)

Prostate cancer detection using multiparametric 3 – tesla MRI and fusion biopsy: preliminary results
by: Thais Caldara Mussi, et al.

Prediction of false-positive PI-RADS 5 lesions on prostate multiparametric MRI: development and internal validation of a clinical-radiological characteristics based nomogram
by: Yongbing Cheng, et al.
Published: (2024-04-01)

Prostatic Inflammation in Prostate Cancer: Protective Effect or Risk Factor?
by: Alessandro Tafuri, et al.
Published: (2021-06-01)

Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2
by: Francesco Sessa, et al.
Published: (2023-01-01)

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
by: Yu-Hao Wang, et al.
Published: (2023-01-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

Nonspecific Presentation of a Multiloculated Prostatic Abscess After Transurethral Prostatic Biopsy for Elevated Prostate-specific Antigen Level
by: Nilay M. Gandhi, et al.
Published: (2014-11-01)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
by: Julie Y. An, et al.
Published: (2017-10-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

Predictors of prostate cancer cetection in MRI PI-RADS 3 lesions – Reality of a terciary center
by: Débora Araújo, et al.
Published: (2023-12-01)

Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study
by: Guan-Hui Cai, et al.
Published: (2021-05-01)

Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer
by: Biagio Barone, et al.
Published: (2023-06-01)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
by: Francesco Porpiglia, et al.
Published: (2015-02-01)

Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece
by: Mario Lourenço, et al.
Published: (2020-01-01)

Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy
by: Yoshiyasu Amiya, et al.
Published: (2015-03-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)